Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.

Revenue
+5.52%
EPS
+258.4%
Free cash flow
−7.81%
Total debt
+47.1%

Quarter to September 2026, against a year earlier

339.76 14.24 −4.02%
Market cap
$64.8B
P/E
18.8×
Fwd P/E
17.5×
Dividend yield
0.71%
F-score
7/9
Altman Z
n/a
Beneish M
−2.59
Dividend safety
70/100

Cencora, Inc. (COR) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Cencora, Inc. (COR) trades at a P/B ratio of 20.0×. Over the past ten years it has ranged from 0.0× (June 2021) to 509× (December 2022); the current reading is higher than 58% of that period. That is above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 17.7× (48.98%)
FY2025 34.7× (38.95%)
FY2024 56.8× 4.34%
FY2023 54.4× (86.25%)
FY2022 396× 840.49%
FY2021 42.1× —
FY2020 0.0× —
FY2019 5.8× (12.79%)
FY2018 6.6× (24.77%)
FY2017 8.8× 9.46%

Quarterly newest first

Period P/B ratio Change
Sep 2026 17.7× 4.83%
Jun 2026 16.9× (1.02%)
Mar 2026 17.0× (45.53%)
Dec 2025 31.3× (9.73%)
43 more quarters

Against its own ten years

Low 0.0× High 509×
Ten-year median 14.0×
Current reading's percentile 53

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on COR